# Immix Biopharma, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/immix-biopharma-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 25 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T04:46:18.168414+00:00 | | Last reviewed | 2026-10-16T04:46:18.168414+00:00 | ## Identity - Legal name: Immix Biopharma, Inc. - Display name: Immix Biopharma, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T13:06:21.568614+00:00 | | Completeness | 0.409 | | Record Quality | 0.84 | | Directors | 9 | | Committees | 5 | | Governance events | 17 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Carey Ng, PhD, MBA: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (member). claim_id=alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:5 - Gabriel Morris, BA: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:6 - Helen C. Adams, CPA: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:7 - Ilya Rachman, MD, PhD, MBA: Director. Status: current. Independent: false. Since: 2012-01-01. claim_id=alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:8 - Jane Buchan, PhD: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance · Chair (member); Compensation (member); Nominating and Governance (chair). claim_id=alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:9 - Jason Hsu, PhD, MS: Director. Status: current. Independent: true. Since: 2013-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:10 - Magda Marquet, PhD: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:11 - Nancy Chang, PhD: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:12 - Yekaterina Chudnovsky, JD: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:13 ## Committees - Audit (audit). Chair: Helen C. Adams, CPA. Members: Helen C. Adams, CPA (chair, current); Carey Ng, PhD, MBA (member, current); Jane Buchan, PhD (member, current). committee_id=alpha:committee:immix-biopharma-inc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Helen C. Adams, CPA (member, current). committee_id=alpha:committee:immix-biopharma-inc:audit-chair - Audit; Compensation; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Jane Buchan, PhD (member, current). committee_id=alpha:committee:immix-biopharma-inc:audit-compensation-nominating-and-governance-chair - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Jane Buchan, PhD (member, current); Jason Hsu, PhD, MS (member, current). committee_id=alpha:committee:immix-biopharma-inc:compensation - Nominating and Governance (nominating_governance). Chair: Jane Buchan, PhD. Members: Jane Buchan, PhD (chair, current); Yekaterina Chudnovsky, JD (member, current). committee_id=alpha:committee:immix-biopharma-inc:nominating-and-governance ## Executive leadership - Gabriel Morris: Chief Financial Officer and President [CFO]. Status: current. claim_id=alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:14 - Ilya Rachman: Chief Executive Officer, Chief Scientific Officer and Chairman of the Board of Directors [CEO]. Status: current. claim_id=alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:15 ## Governance events - CFO_CHANGED: Gabriel Morris executive of Immix Biopharma, Inc., effective 2026-03-25. Effective: 2026-03-25. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:1uojyqqoj6hcc - CEO_CHANGED: Ilya Rachman executive of Immix Biopharma, Inc., effective 2026-03-25. Effective: 2026-03-25. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:r6lea99na7xr - DIRECTOR_APPOINTED: Nancy Chang, PhD seat on Immix Biopharma, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:ycnlz7fx6h91 - DIRECTOR_APPOINTED: Yekaterina Chudnovsky, JD seat on Immix Biopharma, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:y15xfi15amfh2 - COMMITTEE_MEMBER_ADDED: Yekaterina Chudnovsky, JD member of Nominating and Governance, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:1csiyar101gqkf - DIRECTOR_APPOINTED: Gabriel Morris, BA seat on Immix Biopharma, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:1union21pvtzz8 - DIRECTOR_APPOINTED: Helen C. Adams, CPA seat on Immix Biopharma, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:1mii0y31xl9n3x - DIRECTOR_APPOINTED: Jane Buchan, PhD seat on Immix Biopharma, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:1q8mbjv1p61tan - DIRECTOR_APPOINTED: Magda Marquet, PhD seat on Immix Biopharma, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:1c1hd124uuxpy - COMMITTEE_CREATED: Audit · Chair committee of Immix Biopharma, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:uvn81v19yid8t - COMMITTEE_MEMBER_ADDED: Helen C. Adams, CPA member of Audit · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:x2kfoucppsr8 - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance · Chair committee of Immix Biopharma, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:1tt278f90pmmv - COMMITTEE_MEMBER_ADDED: Jane Buchan, PhD member of Audit; Compensation; Nominating and Governance · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:a7z9zduils1t - DIRECTOR_APPOINTED: Carey Ng, PhD, MBA seat on Immix Biopharma, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:szpvys17vzgbc - COMMITTEE_MEMBER_ADDED: Carey Ng, PhD, MBA member of Audit, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:mfxmys1nlxo3m - DIRECTOR_APPOINTED: Jason Hsu, PhD, MS seat on Immix Biopharma, Inc., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:13c1k121oscuqe - DIRECTOR_APPOINTED: Ilya Rachman, MD, PhD, MBA seat on Immix Biopharma, Inc., effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:nl87es1r0bgya ## Scoped resources - `alpha://company/immix-biopharma-inc` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record - `alpha://company/immix-biopharma-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=identity - `alpha://company/immix-biopharma-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=corporate-structure - `alpha://company/immix-biopharma-inc/board` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=board - `alpha://company/immix-biopharma-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=committees - `alpha://company/immix-biopharma-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=leadership - `alpha://company/immix-biopharma-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=ownership - `alpha://company/immix-biopharma-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=financials - `alpha://company/immix-biopharma-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=capital-structure - `alpha://company/immix-biopharma-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=compensation - `alpha://company/immix-biopharma-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=governance - `alpha://company/immix-biopharma-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=shareholder-governance - `alpha://company/immix-biopharma-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=audit - `alpha://company/immix-biopharma-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=legal - `alpha://company/immix-biopharma-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=risk - `alpha://company/immix-biopharma-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=cyber - `alpha://company/immix-biopharma-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=ai-governance - `alpha://company/immix-biopharma-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=agents - `alpha://company/immix-biopharma-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=ecosystem - `alpha://company/immix-biopharma-inc/events` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=events - `alpha://company/immix-biopharma-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=relationships - `alpha://company/immix-biopharma-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=assessments - `alpha://company/immix-biopharma-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:helen-c-adams-cpa","name":"Helen C. Adams, CPA"},"source_id":"board_seats"}` - Claim alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:carey-ng-phd-mba","name":"Carey Ng, PhD, MBA"},"source_id":"board_seats"}` - Claim alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jane-buchan-phd","name":"Jane Buchan, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:jane-buchan-phd","name":"Jane Buchan, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:jason-hsu-phd-ms","name":"Jason Hsu, PhD, MS"},"source_id":"board_seats"}` - Claim alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:jane-buchan-phd","name":"Jane Buchan, PhD"},"source_id":"board_seats"}` - Claim alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:yekaterina-chudnovsky-jd","name":"Yekaterina Chudnovsky, JD"},"source_id":"board_seats"}` ## Leadership - Carey Ng, PhD, MBA: Director, Audit. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:5. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb. - Gabriel Morris, BA: Director. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:6. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb. - Helen C. Adams, CPA: Director, Audit · Chair. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:7. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb. - Ilya Rachman, MD, PhD, MBA: Director. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:8. Valid from: 2012-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb. - Jane Buchan, PhD: Director, Audit; Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb. - Jason Hsu, PhD, MS: Director, Compensation. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:10. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb. - Magda Marquet, PhD: Director. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:11. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb. - Nancy Chang, PhD: Director. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:12. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb. - Yekaterina Chudnovsky, JD: Director, Nominating and Governance. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:13. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb. - Gabriel Morris: Chief Financial Officer and President. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:14. Valid from: 2026-03-25. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62d3e9001f4c5b032c54f51ddcb3501e8f8c3ba927137336c741f1995450d4a4. - Ilya Rachman: Chief Executive Officer, Chief Scientific Officer and Chairman of the Board of Directors. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:leadership_role:15. Valid from: 2026-03-25. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d7afbbd340950f52c0824b6b115e055062fa1a48978b7f2224617542e07ba266. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Helen C. Adams, CPA; Members Helen C. Adams, CPA (Chair); Carey Ng, PhD, MBA; Jane Buchan, PhD. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814. - Compensation: Chair not stated; Members Jane Buchan, PhD; Jason Hsu, PhD, MS. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814. - Nominating and Governance: Chair Jane Buchan, PhD; Members Jane Buchan, PhD (Chair); Yekaterina Chudnovsky, JD. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Immix Biopharma, Inc.. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:64aab320e7b64c28cfd749a1b6f29febf7b65a2f6974fa879ac91d9948dc61fd. ## Entity Status - Public listing published. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:64aab320e7b64c28cfd749a1b6f29febf7b65a2f6974fa879ac91d9948dc61fd. ## Published Fact - US. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:64aab320e7b64c28cfd749a1b6f29febf7b65a2f6974fa879ac91d9948dc61fd. ## Committee Appointment - Helen C. Adams, CPA: chair, Audit. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814. - Carey Ng, PhD, MBA: member, Audit. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814. - Jane Buchan, PhD: member, Audit. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814. - Jane Buchan, PhD: member, Compensation. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814. - Jason Hsu, PhD, MS: member, Compensation. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814. - Jane Buchan, PhD: chair, Nominating and Governance. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814. - Yekaterina Chudnovsky, JD: member, Nominating and Governance. Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814. ## Security Listing - IMMX (NASDAQ). Claim: alpha:claim:company:f097296d-1595-46ca-b4b8-b88a7c5f4e1f:security_listing:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:64aab320e7b64c28cfd749a1b6f29febf7b65a2f6974fa879ac91d9948dc61fd. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:64aab320e7b64c28cfd749a1b6f29febf7b65a2f6974fa879ac91d9948dc61fd: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/immix-biopharma-inc). - alpha:projection-evidence:document:85829158074234eeeb873ac5f12f563eda670934464ec39805bb33c389c1bafb: [Immix Biopharma, Inc. DEF 14A 2026-04-06](https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm). - alpha:projection-evidence:document:62d3e9001f4c5b032c54f51ddcb3501e8f8c3ba927137336c741f1995450d4a4: [IMMX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1873835/000149315226012714/form10-k.htm). - alpha:projection-evidence:document:d7afbbd340950f52c0824b6b115e055062fa1a48978b7f2224617542e07ba266: [IMMX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1873835/000149315226012714/form10-k.htm). - alpha:projection-evidence:75edbe714748401a59705e26a03b2ee049752e4ecd385d198c75450ee63ec814: [Audit](https://www.sec.gov/Archives/edgar/data/1873835/000149315226015320/formdef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/immix-biopharma-inc) - [Public Markdown](https://registry.alpha.ac/companies/immix-biopharma-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/immix-biopharma-inc?format=jsonld) - MCP resource: `alpha://companies/immix-biopharma-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T13:06:21.362063+00:00; recorded 2026-10-16T13:06:21.362063+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.